<DOC>
	<DOCNO>NCT02066727</DOCNO>
	<brief_summary>Hypothesis : Dexmedetomidine adjuvant lidocaine decrease median effective concentration ( EC50 ) lidocaine obturator nerve block transurethral resection bladder tumor</brief_summary>
	<brief_title>Lidocaine Combined Dexmedetomidine Obturator Nerve Block</brief_title>
	<detailed_description>A selective obturator nerve block ( ONB ) effective alternative suppress obturator nerve reflex define sudden , violent adductor muscle spasm obturator nerve stimulate directly electronic resector transurethral resection tumor lateral bladder wall . Studies show Dexmedetomidine adjuvant local anesthetic prolongs peripheral nerve block duration without nerve toxicity . In follow randomize , non-crossover study , investigator test Dexmedetomidine adjuvant decrease median effective concentration ( EC50 ) lidocaine obturator nerve block transurethral resection bladder tumor .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Subjects schedule undergo elective operation TURBT lateral wall ONB need diagnose cystoscopy CT examination preoperatively . 2 . Subject 's American Society Anesthesiologists physical status III . 3 . The subject 's parent/legally authorized guardian give write informed consent participate . 1 . Subject diagnosis abnormal coagulation function . 2 . Subject diagnosis Diabetes mellitus . 3 . Subject preexist neurologic deficit low extremity . 4 . Subject history alcohol drug abuse . 5 . Subject pregnant breastfeeding . 6 . Subject obese ( body mass index &gt; 30kg/m2 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>obturator nerve block</keyword>
	<keyword>lidocaine</keyword>
	<keyword>EC50</keyword>
</DOC>